Valuation: Revvity, Inc.

Market Cap 16.98B 15.16B 14.11B 12.83B 24.23B 1,643B 24.33B 170B 66.52B 838B 63.76B 62.37B 2,688B P/E 2026 *
64.1x
P/E 2027 * 50.5x
Enterprise Value 18.96B 16.94B 15.76B 14.33B 27.06B 1,835B 27.18B 190B 74.3B 936B 71.21B 69.66B 3,003B EV / Sales 2026 *
6.65x
EV / Sales 2027 * 6.13x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+1.54%
1 week+2.11%
Current month+1.20%
1 month+24.93%
3 months+36.99%
6 months+71.05%
Current year+59.93%
1 week 146.7
Extreme 146.7
166.25
1 month 120.9
Extreme 120.895
166.25
Current year 81.22
Extreme 81.22
166.25
1 year 81.22
Extreme 81.22
166.25
3 years 79.5
Extreme 79.5
166.25
5 years 79.5
Extreme 79.5
203.16
10 years 45.35
Extreme 45.35
203.16
Manager TitleAgeSince
Chief Executive Officer 61 30/12/2019
Director of Finance/CFO 37 06/09/2022
Chief Tech/Sci/R&D Officer - 01/05/2023
Director TitleAgeSince
Chairman 68 30/12/2019
Director/Board Member 74 07/02/2012
Director/Board Member 72 27/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 A Sell

Controller/Auditor

-84 0.0001%
9/21/26 A Sell

Chief Financial Officer

-1,631 0.0015%
9/16/26 A Sell

Chief Operating Officer

-7,330 0.0066%
Change 5-day change 1-year change 3-year change Capi.($)
+1.51%+2.11%+68.81%+43.14% 16.98B
+0.89%+0.59%+23.19%+32.76% 241B
+0.98%+2.81%+7.63%+0.78% 153B
+2.01%+8.36%-4.29%+44.23% 147B
+1.17%-0.41%-56.39%-19.04% 60.93B
+0.53%-0.80%+12.34%+15.87% 48.56B
+2.30%+3.38%-19.28%-16.69% 47.69B
+1.59%+2.04%+22.19%+53.85% 47.41B
+3.80%+8.16%-0.95%+38.69% 46.12B
+0.98%+2.09%+31.36%+62.58% 42.16B
Average +1.59%+0.54%+8.46%+25.62% 85.05B
Weighted average by Cap. +1.41%+0.49%+6.90%+24.73%

Financials

2026 *2027 *
Net sales 2.85B 2.55B 2.37B 2.16B 4.07B 276B 4.09B 28.52B 11.18B 141B 10.71B 10.48B 452B 3.01B 2.69B 2.5B 2.27B 4.29B 291B 4.31B 30.06B 11.78B 148B 11.29B 11.04B 476B
Net income 274M 244M 227M 207M 390M 26.49B 392M 2.74B 1.07B 13.5B 1.03B 1.01B 43.33B 346M 309M 288M 262M 494M 33.5B 496M 3.46B 1.36B 17.08B 1.3B 1.27B 54.82B
Net Debt 1.99B 1.77B 1.65B 1.5B 2.83B 192B 2.84B 19.85B 7.78B 97.96B 7.46B 7.29B 314B 1.46B 1.3B 1.21B 1.1B 2.08B 141B 2.09B 14.58B 5.71B 71.95B 5.48B 5.36B 231B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
09/10/26 $154.83 +1.75% 792,337
08/10/26 $152.16 -0.94% 1,456,964
07/10/26 $153.60 +0.20% 2,233,643
06/10/26 $153.30 -2.58% 2,678,780
05/10/26 $157.36 +3.85% 1,551,387
Trader
Investor
Global
Quality
ESG MSCI
AA
Ratings Surperformance© - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
152.16USD
Average target price
141.53USD
Spread / Average Target
-6.98%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.
  1. Stock Market
  2. Stocks
  3. RVTY Stock